Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

休市中 09-11 16:00:00 EDT

6.37

+0.00

0.00%

最高6.37	最低6.37	成交量0.00
今开6.37	昨收6.37	日振幅0.00%
总市值1,425万	流通市值615.24万	总股本223.90万
成交额145.78万	换手率0.00%	流通股本96.66万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":6.365,"timestamp":1757620800000,"preClose":6.365,"halted":8,"volume":0,"delay":0,"floatShares":966600,"shares":2238984,"eps":-9.661975,"marketStatus":"休市中","change":0,"latestTime":"09-11 16:00:00 EDT","open":6.365,"high":6.365,"low":6.365,"amount":1457847.4215676,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.661975,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"BGMS","executeDate":"2025-09-12"},"adr":0,"adrRate":0,"listingDate":1079413200000,"exchange":"NASDAQ","adjPreClose":6.365,"dividendRate":0.000157,"volumeRatio":0},"requestUrl":"/m/hq/s/CYCC","defaultTab":"news","newsList":[{"id":"2558692593","title":"Cyclacel Pharmaceuticals, Inc.8月11日成交额为118.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558692593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558692593?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:54","pubTimestamp":1754963671,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Cyclacel Pharmaceuticals, Inc.成交额为118.25万美元，成交额较昨日减少44.99%，当日成交量为12.86万股。Cyclacel Pharmaceuticals, Inc.于2025年8月11日涨3.08%，报9.05美元，该股过去5个交易日跌7.75%，年初至今跌89.97%，过去60日跌73.99%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|118.25万|-44.99%|12.86万|#|2025-08-08|214.98万|-47.77%|23.10万|#|2025-08-07|411.63万|203.93%|46.34万|#|2025-08-06|135.44万|-90.49%|18.24万|#|2025-08-05|1424.00万|763.20%|161.56万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095437a482f749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095437a482f749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2558503488","title":"Cyclacel Pharmaceuticals, Inc.8月8日成交额为214.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558503488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558503488?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:54","pubTimestamp":1754704463,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Cyclacel Pharmaceuticals, Inc.成交额为214.98万美元，成交额较昨日减少47.77%，当日成交量为23.10万股。Cyclacel Pharmaceuticals, Inc.于2025年8月8日跌2.12%，报8.78美元，该股过去5个交易日跌9.67%，年初至今跌90.27%，过去60日跌78.72%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|214.98万|-47.77%|23.10万|#|2025-08-07|411.63万|203.93%|46.34万|#|2025-08-06|135.44万|-90.49%|18.24万|#|2025-08-05|1424.00万|763.20%|161.56万|#|2025-08-04|164.97万|12.23%|16.93万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095427a6dbe7b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095427a6dbe7b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2557515570","title":"Cyclacel Pharmaceuticals, Inc.8月7日成交额为411.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515570?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:53","pubTimestamp":1754617980,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Cyclacel Pharmaceuticals, Inc.成交额为411.63万美元，成交额较昨日增加203.93%，当日成交量为46.34万股。Cyclacel Pharmaceuticals, Inc.于2025年8月7日涨21.05%，报8.97美元，该股过去5个交易日跌19.98%，年初至今跌90.06%，过去60日跌83.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|411.63万|203.93%|46.34万|#|2025-08-06|135.44万|-90.49%|18.24万|#|2025-08-05|1424.00万|763.20%|161.56万|#|2025-08-04|164.97万|12.23%|16.93万|#|2025-08-01|146.99万|6.80%|14.54万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095304a6d9de37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095304a6d9de37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2557582662","title":"Cyclacel Pharmaceuticals, Inc.8月6日成交额为135.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557582662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557582662?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:51","pubTimestamp":1754531475,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Cyclacel Pharmaceuticals, Inc.成交额为135.44万美元，成交额较昨日减少90.49%，当日成交量为18.24万股。Cyclacel Pharmaceuticals, Inc.于2025年8月6日跌9.74%，报7.41美元，该股过去5个交易日跌40.19%，年初至今跌91.79%，过去60日跌87.8%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|135.44万|-90.49%|18.24万|#|2025-08-05|1424.00万|763.20%|161.56万|#|2025-08-04|164.97万|12.23%|16.93万|#|2025-08-01|146.99万|6.80%|14.54万|#|2025-07-31|137.64万|-31.15%|11.78万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807095117a6d7a0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807095117a6d7a0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2557507370","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘急速下跌8.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557507370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557507370?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:31","pubTimestamp":1754487083,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速跳水8.65%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Fortrea Holdings Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为320.52%、271.85%、13.68%，振幅较大的相关个股有Fortrea Holdings Inc.、Biomx Inc.、Fractyl Health, Inc.，振幅分别为11.74%、9.77%、8.82%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621312394d37c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621312394d37c0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2557349682","title":"Cyclacel Pharmaceuticals, Inc.8月5日成交额为1424.00万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557349682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557349682?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:49","pubTimestamp":1754444958,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Cyclacel Pharmaceuticals, Inc.成交额为1424.00万美元，成交额较昨日增加763.20%，当日成交量为161.56万股。Cyclacel Pharmaceuticals, Inc.于2025年8月5日跌16.31%，报8.21美元，该股过去5个交易日跌38.04%，年初至今跌90.9%，过去60日跌88.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|1424.00万|763.20%|161.56万|#|2025-08-04|164.97万|12.23%|16.93万|#|2025-08-01|146.99万|6.80%|14.54万|#|2025-07-31|137.64万|-31.15%|11.78万|#|2025-07-30|199.91万|-40.75%|15.33万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094926a4779b42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094926a4779b42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2557355211","title":"Cyclacel Pharmaceuticals, Inc.8月4日成交额为164.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557355211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557355211?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:48","pubTimestamp":1754358501,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Cyclacel Pharmaceuticals, Inc.成交额为164.97万美元，成交额较昨日增加12.23%，当日成交量为16.93万股。Cyclacel Pharmaceuticals, Inc.于2025年8月4日涨0.93%，报9.81美元，该股过去5个交易日跌36.26%，年初至今跌89.13%，过去60日跌87.15%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|164.97万|12.23%|16.93万|#|2025-08-01|146.99万|6.80%|14.54万|#|2025-07-31|137.64万|-31.15%|11.78万|#|2025-07-30|199.91万|-40.75%|15.33万|#|2025-07-29|337.37万|11.36%|25.06万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094825a6d36654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094825a6d36654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2556954842","title":"Cyclacel Pharmaceuticals, Inc.8月1日成交额为146.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556954842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556954842?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:48","pubTimestamp":1754099281,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Cyclacel Pharmaceuticals, Inc.成交额为146.99万美元，成交额较昨日增加6.80%，当日成交量为14.54万股。Cyclacel Pharmaceuticals, Inc.于2025年8月1日跌13.29%，报9.72美元，该股过去5个交易日跌39.4%，年初至今跌89.23%，过去60日跌88.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|146.99万|6.80%|14.54万|#|2025-07-31|137.64万|-31.15%|11.78万|#|2025-07-30|199.91万|-40.75%|15.33万|#|2025-07-29|337.37万|11.36%|25.06万|#|2025-07-28|302.95万|-60.66%|19.56万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802094810a4709ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802094810a4709ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2556687218","title":"Cyclacel Pharmaceuticals, Inc.7月31日成交额为137.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556687218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556687218?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:47","pubTimestamp":1754012861,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Cyclacel Pharmaceuticals, Inc.成交额为137.64万美元，成交额较昨日减少31.15%，当日成交量为11.78万股。Cyclacel Pharmaceuticals, Inc.于2025年7月31日跌9.52%，报11.21美元，该股过去5个交易日跌34.64%，年初至今跌87.58%，过去60日跌84.38%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-31|137.64万|-31.15%|11.78万|#|2025-07-30|199.91万|-40.75%|15.33万|#|2025-07-29|337.37万|11.36%|25.06万|#|2025-07-28|302.95万|-60.66%|19.56万|#|2025-07-25|770.12万|-92.81%|46.34万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094750a6ccaf16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094750a6ccaf16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2555909524","title":"Cyclacel Pharmaceuticals, Inc.7月29日成交额为337.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555909524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555909524?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:52","pubTimestamp":1753840324,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Cyclacel Pharmaceuticals, Inc.成交额为337.37万美元，成交额较昨日增加11.36%，当日成交量为25.06万股。Cyclacel Pharmaceuticals, Inc.于2025年7月29日跌13.91%，报13.25美元，该股过去5个交易日涨23.14%，年初至今跌85.32%，过去60日跌77.47%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|337.37万|11.36%|25.06万|#|2025-07-28|302.95万|-60.66%|19.56万|#|2025-07-25|770.12万|-92.81%|46.34万|#|2025-07-24|1.07亿|355.78%|622.45万|#|2025-07-23|2351.00万|474.32%|172.58万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095215a6c8b5f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095215a6c8b5f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2555083789","title":"Cyclacel Pharmaceuticals, Inc.7月28日成交额为302.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555083789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555083789?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:50","pubTimestamp":1753753815,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Cyclacel Pharmaceuticals, Inc.成交额为302.95万美元，成交额较昨日减少60.66%，当日成交量为19.56万股。Cyclacel Pharmaceuticals, Inc.于2025年7月28日跌4.05%，报15.39美元，该股过去5个交易日涨31.99%，年初至今跌82.95%，过去60日跌75.15%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-28|302.95万|-60.66%|19.56万|#|2025-07-25|770.12万|-92.81%|46.34万|#|2025-07-24|1.07亿|355.78%|622.45万|#|2025-07-23|2351.00万|474.32%|172.58万|#|2025-07-22|409.35万|-67.04%|34.68万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095018a6c6d1f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095018a6c6d1f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2554181187","title":"Cyclacel Pharmaceuticals, Inc.7月25日成交额为770.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554181187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554181187?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:50","pubTimestamp":1753494641,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Cyclacel Pharmaceuticals, Inc.成交额为770.12万美元，成交额较昨日减少92.81%，当日成交量为46.34万股。Cyclacel Pharmaceuticals, Inc.于2025年7月25日跌6.47%，报16.04美元，该股过去5个交易日涨22.72%，年初至今跌82.23%，过去60日跌78.02%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-25|770.12万|-92.81%|46.34万|#|2025-07-24|1.07亿|355.78%|622.45万|#|2025-07-23|2351.00万|474.32%|172.58万|#|2025-07-22|409.35万|-67.04%|34.68万|#|2025-07-21|1241.85万|-96.24%|98.09万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726095052a6c27402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726095052a6c27402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2553222221","title":"Cyclacel Pharmaceuticals, Inc.7月23日成交额为2351.00万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222221","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222221?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:47","pubTimestamp":1753321663,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Cyclacel Pharmaceuticals, Inc.成交额为2351.00万美元，成交额较昨日增加474.32%，当日成交量为172.58万股。Cyclacel Pharmaceuticals, Inc.于2025年7月23日涨30.11%，报14.0美元，该股过去5个交易日涨70.73%，年初至今跌84.49%，过去60日跌79.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|2351.00万|474.32%|172.58万|#|2025-07-22|409.35万|-67.04%|34.68万|#|2025-07-21|1241.85万|-96.24%|98.09万|#|2025-07-18|3.30亿|2798.11%|2236.92万|#|2025-07-17|1140.02万|-63.70%|132.67万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094745a46021e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094745a46021e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2553226060","title":"Cyclacel Pharmaceuticals, Inc.7月22日成交额为409.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553226060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553226060?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:46","pubTimestamp":1753235184,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Cyclacel Pharmaceuticals, Inc.成交额为409.35万美元，成交额较昨日减少67.04%，当日成交量为34.68万股。Cyclacel Pharmaceuticals, Inc.于2025年7月22日跌7.72%，报10.76美元，该股过去5个交易日跌12.73%，年初至今跌88.08%，过去60日跌80.42%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-22|409.35万|-67.04%|34.68万|#|2025-07-21|1241.85万|-96.24%|98.09万|#|2025-07-18|3.30亿|2798.11%|2236.92万|#|2025-07-17|1140.02万|-63.70%|132.67万|#|2025-07-16|3140.30万|-96.25%|355.38万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094636a45d9761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094636a45d9761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":1},{"id":"2553928332","title":"Cyclacel Pharmaceuticals, Inc.7月21日成交额为1241.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553928332","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553928332?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:46","pubTimestamp":1753148763,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Cyclacel Pharmaceuticals, Inc.成交额为1241.85万美元，成交额较昨日减少96.24%，当日成交量为98.09万股。Cyclacel Pharmaceuticals, Inc.于2025年7月21日跌10.79%，报11.66美元，该股过去5个交易日涨252.27%，年初至今跌87.08%，过去60日跌78.88%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-21|1241.85万|-96.24%|98.09万|#|2025-07-18|3.30亿|2798.11%|2236.92万|#|2025-07-17|1140.02万|-63.70%|132.67万|#|2025-07-16|3140.30万|-96.25%|355.38万|#|2025-07-15|8.38亿|180445.05%|6378.66万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094613a45ae98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094613a45ae98b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":1},{"id":"2551849221","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551849221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551849221?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:38","pubTimestamp":1752500299,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时38分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.93%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Dare Bioscience, Inc.、Promis Neurosciences Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1638.87%、393.49%、172.24%，振幅较大的相关个股有Biomx Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.，振幅分别为78.63%、70.78%、56.35%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213819a6a8f2dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213819a6a8f2dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2550952886","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952886?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:17","pubTimestamp":1752243479,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时17分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.46%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Seastar Medical Holding Corp C/Wts 28/10/2027 、Alterity Therapeutics Limited、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Cel-Sci Corporation、Dare Bioscience, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为183.73%、81.17%、26.88%，振幅较大的相关个股有Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为73.30%、35.73%、29.71%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711221759a4451174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711221759a4451174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2550165337","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550165337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550165337?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:41","pubTimestamp":1752068513,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时41分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.05%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Calidi Biotherapeutics, Inc.、Prokidney Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为638.36%、557.57%、404.60%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为56.72%、34.33%、29.77%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214154a4407e25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214154a4407e25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2549528939","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528939?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:30","pubTimestamp":1751981406,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时30分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水7.00%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Prokidney Corp.、Rallybio Corporation、Context Therapeutics Inc.涨幅较大，Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为782.05%、118.24%、109.34%，振幅较大的相关个股有Vanda Pharmaceuticals Inc.、Orchestra Biomed Holdings, Inc.、Can Fite Biopharma Ltd，振幅分别为1.42%、1.30%、0.98%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213006979e61c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213006979e61c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2549530017","title":"Cyclacel Pharmaceuticals, Inc.股价飙升10.45% 市值涨64.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530017?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:30","pubTimestamp":1751895004,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时30分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升10.45%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1313.12%、736.33%、648.57%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症及其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721300495399c73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721300495399c73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.106},{"period":"6month","weight":0.1468},{"period":"1year","weight":-0.9348},{"period":"ytd","weight":-0.9295}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.210526,"avgChangeRate":-0.011871},{"month":2,"riseRate":0.421053,"avgChangeRate":0.076812},{"month":3,"riseRate":0.368421,"avgChangeRate":-0.064253},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014837},{"month":5,"riseRate":0.4,"avgChangeRate":-0.040969},{"month":6,"riseRate":0.15,"avgChangeRate":-0.136709},{"month":7,"riseRate":0.55,"avgChangeRate":0.026347},{"month":8,"riseRate":0.25,"avgChangeRate":-0.102296},{"month":9,"riseRate":0.45,"avgChangeRate":-0.019544},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.007856},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.031831},{"month":12,"riseRate":0.473684,"avgChangeRate":-0.021725}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}